Dai ichi Life Insurance Company Ltd Has $6.19 Million Stock Position in Royalty Pharma PLC $RPRXMarket Beat·2 days ago, 03:01 AMRPRX+2.11%
Analyst Reiterates Buy on Prothena, Maintains $30 Price Target on Differentiated TTR-Depleter OpportunityTip Ranks·Jul 24 at 07:25 AMPRTA-1.61%RPRX+2.11%
CI Investments Inc. Has $8.33 Million Stock Holdings in Royalty Pharma PLC $RPRXMarket Beat·Jul 24 at 03:01 AMRPRX+2.11%PNC+0.79%
Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune | RPRX Stock NewsStockTitan·Jul 21 at 10:05 PMAZN+1.67%RPRX+2.11%
Royalty Pharma declares third quarter 2026 dividend | RPRX Stock NewsStockTitan·Jul 17 at 07:15 AMRPRX+2.11%
